Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LSTA

Lisata Therapeutics (LSTA)

Lisata Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LSTA
DateTimeSourceHeadlineSymbolCompany
28/02/202508:05GlobeNewswire Inc.Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
21/02/202500:00GlobeNewswire Inc.Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025NASDAQ:LSTALisata Therapeutics Inc
06/02/202500:30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 BIO CEO & Investor ConferenceNASDAQ:LSTALisata Therapeutics Inc
24/01/202500:00GlobeNewswire Inc.Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
23/01/202500:00GlobeNewswire Inc.Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
16/01/202500:30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 Sequire Investor SummitNASDAQ:LSTALisata Therapeutics Inc
11/12/202400:30GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
04/12/202400:30GlobeNewswire Inc.Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor ImagingNASDAQ:LSTALisata Therapeutics Inc
20/11/202400:30GlobeNewswire Inc.Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’NASDAQ:LSTALisata Therapeutics Inc
13/11/202408:05GlobeNewswire Inc.Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
07/11/202401:23GlobeNewswire Inc.Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research CollaborationNASDAQ:LSTALisata Therapeutics Inc
07/11/202400:30GlobeNewswire Inc.Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024NASDAQ:LSTALisata Therapeutics Inc
31/10/202423:30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
28/10/202423:30GlobeNewswire Inc.Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of EndometriosisNASDAQ:LSTALisata Therapeutics Inc
03/10/202422:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
17/09/202422:00GlobeNewswire Inc.Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER TrialNASDAQ:LSTALisata Therapeutics Inc
09/09/202422:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
05/09/202422:00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
13/08/202406:05GlobeNewswire Inc.Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
05/08/202422:00GlobeNewswire Inc.Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024NASDAQ:LSTALisata Therapeutics Inc
18/07/202422:00GlobeNewswire Inc.Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer TherapyNASDAQ:LSTALisata Therapeutics Inc
16/07/202422:00GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
10/07/202422:00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical ModelNASDAQ:LSTALisata Therapeutics Inc
13/06/202422:30GlobeNewswire Inc.Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
28/05/202422:30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
20/05/202422:30GlobeNewswire Inc.Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic CancerNASDAQ:LSTALisata Therapeutics Inc
10/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LSTALisata Therapeutics Inc
10/05/202406:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LSTALisata Therapeutics Inc
10/05/202406:05GlobeNewswire Inc.Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
08/05/202422:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LSTA